QDEL Stock Price, Quidel Corp Quote, Chart

Market Summary

USD41.43-0.74

Market Closed

-1.75%

QDEL Stock Price

View Fullscreen

QDEL RSI Chart

QDEL Valuation

Market Cap

2.8B

Price/Earnings (Trailing)

-274.22

Price/Sales (Trailing)

0.92

EV/EBITDA

17.56

Price/Free Cashflow

39.06

QDEL Price/Sales (Trailing)

QDEL Profitability

Operating Margin

97.96%

EBT Margin

-0.97%

Return on Equity

-0.2%

Return on Assets

-0.12%

Free Cashflow Yield

2.56%

QDEL Fundamentals

QDEL Revenue

Revenue (TTM)

3.0B

Rev. Growth (Yr)

-14.3%

Rev. Growth (Qtr)

-0.19%

QDEL Earnings

Earnings (TTM)

-10.1M

Earnings Growth (Yr)

-76.9%

Earnings Growth (Qtr)

155.12%

Breaking Down QDEL Revenue

Last 7 days

-4.4%

Last 30 days

-14.4%

Last 90 days

-43.2%

Trailing 12 Months

-56.0%

How does QDEL drawdown profile look like?

QDEL Financial Health

Current Ratio

1.57

Debt/Equity

0.45

Debt/Cashflow

0.12

QDEL Investor Care

Shares Dilution (1Y)

0.52%

Diluted EPS (TTM)

-0.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	3.1B	3.2B	3.1B	3.0B
2022	2.3B	2.8B	3.0B	3.3B
2021	0	1.7B	1.7B	1.7B
2020	0	0	0	1.7B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Quidel Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	hodges michelle a.	acquired	-	-	2,462	svp, general counsel
Mar 28, 2024	bujarski robert joseph	acquired	-	-	4,925	interim president, evp & coo
Mar 28, 2024	hodges michelle a.	sold (taxes)	-42,139	47.94	-879	svp, general counsel
Mar 28, 2024	busky joseph m	sold (taxes)	-107,098	47.94	-2,234	chief financial officer
Mar 28, 2024	iskra michael s.	acquired	-	-	4,925	interim ceo, evp & cco
Mar 28, 2024	iskra michael s.	sold (taxes)	-84,997	47.94	-1,773	interim ceo, evp & cco
Mar 28, 2024	kroll werner	acquired	-	-	3,811	svp, research & development
Mar 28, 2024	bujarski robert joseph	sold (taxes)	-134,472	47.94	-2,805	interim president, evp & coo
Mar 28, 2024	busky joseph m	acquired	-	-	4,925	chief financial officer
Mar 28, 2024	kroll werner	sold (taxes)	-86,339	47.94	-1,801	svp, research & development

Which funds bought or sold QDEL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 12, 2024	Unison Advisors LLC	unchanged	-	-125,296	233,181	0.02%
Apr 12, 2024	WASHINGTON CAPITAL MANAGEMENT, INC	sold off	-100	-530,640	-	-%
Apr 12, 2024	First PREMIER Bank	unchanged	-	-5,000	10,000	-%
Apr 12, 2024	Pacifica Partners Inc.	unchanged	-	-1,902	4,739	-%
Apr 12, 2024	INSPIRION WEALTH ADVISORS, LLC	unchanged	-	-303,504	543,112	0.09%
Apr 10, 2024	Yarbrough Capital, LLC	unchanged	-	-220,274	409,935	0.02%
Apr 09, 2024	Rise Advisors, LLC	unchanged	-	-7,084	13,184	0.01%
Apr 09, 2024	MASSMUTUAL TRUST CO FSB/ADV	reduced	-41.18	-1,547	959	-%
Apr 09, 2024	MATHER GROUP, LLC.	new	-	369	369	-%
Apr 05, 2024	GAMMA Investing LLC	added	1,871	62,252	67,116	0.01%

Are Funds Buying or Selling QDEL?

Are funds buying QDEL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own QDEL

No. of Funds

Unveiling Quidel Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	13.0%	8,698,143	SC 13G/A
Feb 13, 2024	vanguard group inc	7.25%	4,841,410	SC 13G/A
Jan 26, 2024	blackrock inc.	7.2%	4,797,921	SC 13G/A
May 05, 2022	senvest management, llc	5.17%	2,161,521	SC 13G
Feb 14, 2022	alger associates inc	5.3%	2,223,343	SC 13G
Feb 14, 2022	price t rowe associates inc /md/	14.6%	6,108,899	SC 13G/A
Feb 14, 2022	brown capital management llc	6.34%	2,642,671	SC 13G/A
Feb 10, 2022	vanguard group inc	8.22%	3,426,080	SC 13G/A
Feb 01, 2022	blackrock inc.	7.9%	3,301,994	SC 13G/A
Apr 12, 2021	price t rowe associates inc /md/	15.1%	6,425,323	SC 13G/A

Recent SEC filings of Quidel Corp

View All Filings

Date Filed	Form Type	Document
Apr 02, 2024	ARS	ARS
Apr 02, 2024	DEF 14A	DEF 14A
Apr 02, 2024	DEFA14A	DEFA14A
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Feb 29, 2024	4	Insider Trading
Feb 29, 2024	8-K/A	Current Report

Quidel Corp News

Latest updates

Quidel Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)												(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Revenue	-0.2%	743	744	665	846	867	784	613	1,002	637	510	177	-
Gross Profit	-	-	-	-	-	-	-	-	740	489	373	106	701
Costs and Expenses	-	-	-	-	-	-	-	-	119	113	92.00	83.00	84.00
S&GA Expenses	-3.3%	188	194	179	202	214	204	118	85.00	74.00	63.00	54.00	-
R&D Expenses	-5.0%	59.00	62.00	63.00	62.00	64.00	66.00	34.00	26.00	26.00	24.00	23.00	-
EBITDA Margin	-12.5%	0.09*	0.11*	0.12*	0.14*	0.29*	0.40*	0.51*	0.58*	0.56*	0.64*	0.64*	0.65*
Interest Expenses	2.7%	-36.70	-37.70	-36.50	-36.70	-34.70	-29.70	-10.30	-1.00	-1.10	-1.30	-1.40	-
Income Taxes	-478.6%	-16.20	-2.80	-11.20	11.00	11.00	12.00	24.00	141	84.00	66.00	3.00	-
Earnings Before Taxes	40.6%	-9.20	-15.50	-64.40	60.00	41.00	31.00	43.00	621	375	282	22.00	-
EBT Margin	-242.9%	-0.01*	0.01*	0.02*	0.06*	0.23*	0.35*	0.48*	0.56*	0.53*	0.62*	0.62*	0.63*
Net Income	155.1%	7.00	-12.70	-53.20	49.00	30.00	19.00	19.00	480	291	216	19.00	-
Net Income Margin	-179.7%	0.00*	0.00*	0.01*	0.04*	0.17*	0.27*	0.36*	0.43*	0.41*	0.48*	0.48*	0.49*
Free Cashflow	1773.7%	32.00	-1.90	-81.90	123	108	-40.20	199	478	289	-29.90	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet								(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2021Q4
Assets	0.3%	8,563	8,539	8,550	8,787	8,856	8,656	8,822	2,430
Current Assets	-4.4%	1,311	1,371	1,308	1,499	1,575	1,445	1,559	1,440
Cash Equivalents	-20.4%	119	149	179	354	293	213	381	803
Inventory	4.7%	578	552	542	529	524	536	553	199
Net PPE	5.4%	1,444	1,369	1,376	1,362	1,339	1,262	1,110	349
Goodwill	2.0%	2,492	2,443	2,471	2,491	2,477	2,358	2,590	337
Liabilities	-0.4%	3,557	3,572	3,548	3,791	3,921	3,860	3,903	501
Current Liabilities	-3.0%	834	860	790	908	1,007	873	900	324
Long Term Debt	0.0%	2,275	2,275	2,309	2,380	2,431	2,482	2,533	0.00
Shareholder's Equity	0.8%	5,006	4,967	5,003	4,997	4,935	4,795	4,920	1,929
Retained Earnings	0.3%	2,188	2,181	2,194	2,247	2,198	2,168	2,148	1,649
Additional Paid-In Capital	0.3%	2,848	2,839	2,825	2,809	2,804	2,772	2,832	280
Shares Outstanding	-0.1%	67.00	67.00	67.00	67.00	66.00	67.00	47.00	42.00
Float	-	-	-	5,090	-	-	-	6,008	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)												(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Cashflow From Operations	93.7%	80.00	42.00	-30.60	189	169	-9.70	225	501	321	77.00	-	-
Share Based Compensation	-12.8%	12.00	14.00	14.00	11.00	12.00	13.00	16.00	7.00	7.00	7.00	-	-
Cashflow From Investing	-158.7%	-55.10	-21.30	-42.30	-68.90	-59.30	-29.80	-1,530	-24.70	-96.00	-93.20	-	-
Cashflow From Financing	-18.7%	-57.80	-48.70	-99.70	-59.60	-31.70	-126	413	-3.40	-0.90	2.00	-	-
Buy Backs	-	7.00	-	-	-	-	74.00	-	-	-	-	103	-

QDEL Income Statement

2023-12-31

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Jan. 02, 2022
Income Statement [Abstract]
Total revenues	$ 2,997.8	$ 3,266.0	$ 1,698.6
Cost of sales, excluding amortization of intangibles	1,503.4	1,330.0	420.3
Selling, marketing and administrative	763.2	621.0	239.6
Research and development	246.8	190.5	95.7
Amortization of intangible assets	204.8	132.5	27.4
Acquisition and integration costs	113.4	136.0	9.6
Other operating expenses	27.1	12.3	0.0
Operating income	139.1	843.7	906.0
Interest expense, net	147.6	75.7	5.8
Loss on extinguishment of debt	0.0	24.0	0.0
Other expense (income), net	20.6	8.1	(0.1)
(Loss) income before income taxes	(29.1)	735.9	900.3
(Benefit from) provision for income taxes	(19.0)	187.2	196.1
Net (loss) income	$ (10.1)	$ 548.7	$ 704.2
Basic (loss) earnings per share	$ (0.15)	$ 9.66	$ 16.74
Diluted (loss) earnings per share	$ (0.15)	$ 9.56	$ 16.43
Weighted-average shares outstanding - basic	66.8	56.8	42.1
Weighted-average shares outstanding - diluted	66.8	57.4	42.9

QDEL Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Jan. 01, 2023
Current assets:
Cash and cash equivalents	$ 118.9	$ 292.9
Marketable securities	48.4	52.1
Accounts receivable, net	303.3	453.9
Inventories	577.8	524.1
Prepaid expenses and other current assets	262.1	252.1
Total current assets	1,310.5	1,575.1
Property, plant and equipment, net	1,443.8	1,339.0
Marketable securities	7.4	21.0
Right-of-use assets	169.6	181.0
Goodwill	2,492.0	2,476.8
Intangible assets, net	2,934.3	3,123.8
Deferred tax asset	25.9	16.4
Other assets	179.6	122.7
Total assets	8,563.1	8,855.8
Current liabilities:
Accounts payable	294.8	283.3
Accrued payroll and related expenses	84.8	139.2
Income tax payable	11.1	51.6
Current portion of borrowings	139.8	207.5
Other current liabilities	303.3	325.4
Total current liabilities	833.8	1,007.0
Operating lease liabilities	172.8	186.4
Long-term borrowings	2,274.8	2,430.8
Deferred tax liability	192.2	213.2
Other liabilities	83.6	83.8
Total liabilities	3,557.2	3,921.2
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at December 31, 2023 and January 1, 2023	0.0	0.0
Common stock, $0.001 par value per share; 126.2 shares authorized; 66.7 and 66.4 shares issued and outstanding at December 31, 2023 and January 1, 2023, respectively	0.1	0.0
Additional paid-in capital	2,848.0	2,804.3
Accumulated other comprehensive loss	(30.0)	(67.6)
Retained earnings	2,187.8	2,197.9
Total stockholders’ equity	5,005.9	4,934.6
Total liabilities and stockholders’ equity	$ 8,563.1	$ 8,855.8

About Quidel Corp

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

CEO	Mr. Douglas C. Bryant
WEBSITE	quidelortho.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	7000

Quidel Corp Frequently Asked Questions

What is the ticker symbol for Quidel Corp? What does QDEL stand for in stocks?

QDEL is the stock ticker symbol of Quidel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Quidel Corp (QDEL)?

As of Mon Apr 15 2024, market cap of Quidel Corp is 2.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of QDEL stock?

You can check QDEL's fair value in chart for subscribers.

What is the fair value of QDEL stock?

You can check QDEL's fair value in chart for subscribers. The fair value of Quidel Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Quidel Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for QDEL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Quidel Corp a good stock to buy?

The fair value guage provides a quick view whether QDEL is over valued or under valued. Whether Quidel Corp is cheap or expensive depends on the assumptions which impact Quidel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for QDEL.

What is Quidel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, QDEL's PE ratio (Price to Earnings) is -274.22 and Price to Sales (PS) ratio is 0.92. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. QDEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Quidel Corp's stock?

In the past 10 years, Quidel Corp has provided 0.055 (multiply by 100 for percentage) rate of return.